XML 22 R15.htm IDEA: XBRL DOCUMENT
v3.25.3

Convertible Preferred Stock and Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2025
Convertible Preferred Stock And Stockholders Deficit Disclosure [Abstract] |
Convertible Preferred Stock and Stockholders’ Equity | 8. Convertible Preferred Stock and Stockholders’ Equity Convertible Preferred Stock In November 2016, the Company completed a private placement of stock in which investors, including investors affiliated with the directors and officers of the Company, purchased convertible preferred stock and common stock of the Company (the November 2016 Placement). The Company issued 2,819,549 shares of Class A Convertible Preferred Stock, $0.001 par value per share (the Class A Preferred), at $13.30 per share, each of which is convertible into five shares of common stock upon certain conditions defined in the Certificate of Designation of Preferences, Rights and Limitations of the Class A Preferred filed with the Delaware Secretary of State on November 22, 2016 (the CoD). The Class A Preferred were purchased exclusively by entities affiliated with Redmile Group, LLC (collectively, Redmile). The terms of the CoD prohibited Redmile from converting the Class A Preferred into shares of the Company’s common stock if, as a result of conversion, Redmile, together with its affiliates, would own more than 9.99% of the Company’s common stock then issued and outstanding (the Redmile Percentage Limitation), which percentage could change at Redmile’s election upon 61 days’ notice to the Company to (i) any other number less than or equal to 19.99% or (ii) subject to approval of the Company’s stockholders to the extent required in accordance with the Nasdaq Global Market rules, any number in excess of 19.99%. On May 2, 2017, the Company’s stockholders approved the issuance of up to an aggregate of 14,097,745 shares of common stock upon the conversion of the outstanding shares of Class A Preferred. As a result, Redmile has the right to increase the Redmile Percentage Limitation to any percentage in excess of 19.99% at its election. The Company also issued 7,236,837 shares of common stock at $2.66 per share as part of the November 2016 Placement. In April 2023, the Company filed with the office of the Secretary of State of the State of Delaware a Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock which amends the definition of Beneficial Ownership Limitation to be 14.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock pursuant to a Notice of Conversion. In April 2023, 33,441 shares of Class A Preferred were converted into 167,205 shares of the Company’s common stock. In December 202 4, 6,022 shares of the Class A Preferred were converted into 30,110 shares of the Company’s common stock. In July 2025, Redmile provided the Company with notice of its intent to increase the Redmile Percentage Limitation from 9.99% to 14.99%, which became effective on August 31, 2025. The Class A Preferred are non-voting shares and are convertible into five shares of the Company’s common stock at a conversion price of $2.66 per share, which was the fair value of the Company’s common stock on the date of issuance. Holders of the Class A Preferred have the same dividend rights as holders of the Company’s common stock. Additionally, the liquidation preferences of the Class A Preferred are pari passu among holders of the Company’s common stock and holders of the Class A Preferred, pro rata based on the number of shares held by each such holder (treated for this purpose as if the Class A Preferred had been converted to common stock). Pre-Funded Warrants In January 2021, in conjunction with a public offering, the Company issued pre-funded warrants, in lieu of common stock to certain investors, to purchase 257,310 shares of the Company’s common stock (the 2021 Pre-Funded Warrants). The purchase price for the 2021 Pre-Funded Warrants was $85.499 per pre-funded warrant, which equals the per share public offering price for the shares of common stock less the $0.001 exercise price for each such pre-funded warrant. Given that the 2021 Pre-Funded Warrants are indexed to the Company’s own shares of common stock (and otherwise meet the requirements to be classified in equity), the Company recorded the consideration received from the issuance of the warrants as additional paid-in capital on the Company’s consolidated balance sheets. In March 2024, in conjunction with a public offering, the Company issued in a private placement, in lieu of common stock to certain investors, pre-funded warrants to purchase 3,636,364 shares of the Company’s common stock (2024 Pre-Funded Warrants, and collectively with the 2021 Pre-Funded Warrants, the Pre-Funded Warrants). The purchase price for the 2024 Pre-Funded Warrants was $5.499 per pre-funded warrant, which equals the per share public offering price for the shares of common stock issued in the March 2024 public offering, less the $0.001 exercise price for each such pre-funded warrant. Given that the 2024 Pre-Funded Warrants are indexed to the Company’s own shares of common stock (and otherwise meet the requirements to be classified in equity), the Company recorded the consideration received from the issuance of the warrants as additional paid-in capital on the Company’s unaudited condensed consolidated balance sheets. The Pre-Funded Warrants are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage not in excess of 19.99% by providing at least 61 days’ prior notice to the Company. As of September 30, 2025, there wer e 3,893,674 Pre-Funded Warrants outstanding. Stock Options and Restricted Stock Unit Awards The following table summarizes stock option activity and related information under all equity plans for the period ended September 30, 2025:
|  | Number of Options |  |  | Weighted- Average Price |
Balance at December 31, 2024 |  |  | 10,722,674 |  |  | $ | 10.99 |
Granted |  |  | 3,690,400 |  |  |  | 1.29 |
Exercised |  |  | (832 | ) |  |  | 1.32 |
Cancelled |  |  | (1,814,843 | ) |  |  | 7.45 |
Balance at September 30, 2025 |  |  | 12,597,399 |  |  | $ | 8.66 |
Restricted stock unit activity under all equity and stock option plans is summarized as follows:
|  | Number of Restricted Stock Units |  |  | Weighted- Average Grant Date Fair Value per Share |
Balance at December 31, 2024 |  |  | 6,214,064 |  |  | $ | 15.50 |
Granted |  |  | 3,395,020 |  |  |  | 1.20 |
Vested |  |  | (1,407,586 | ) |  |  | 15.79 |
Cancelled |  |  | (1,554,405 | ) |  |  | 7.59 |
Balance at September 30, 2025 |  |  | 6,647,093 |  |  | $ | 9.98 |
The allocation of stock-based compensation for all stock awards is as follows (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Research and development |  | $ | 2,448 |  |  | $ | 5,295 |  |  | $ | 10,146 |  |  | $ | 16,248 |
General and administrative |  |  | 2,413 |  |  |  | 6,470 |  |  |  | 9,250 |  |  |  | 16,128 |
Total |  | $ | 4,861 |  |  | $ | 11,765 |  |  | $ | 19,396 |  |  | $ | 32,376 |
As of September 30, 2025, the unrecognized compensation cost related to outstanding options was $6.8 million and is expected to be recognized as expense over a weighted-average period of approximately 1.5 years. As of September 30, 2025, the unrecognized compensation cost related to restricted stock units was $14.9 million which is expected to be recognized as expense over a weighted-average period of approximately 1.6 years. The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:
|  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Risk-free interest rate |  |  | 4.4 | % |  |  | 3.9 | %
Expected volatility |  |  | 90.4 | % |  |  | 87.1 | %
Expected term (in years) |  |  | 6.2 |  |  |  | 6.4 |
Expected dividend yield |  |  | 0.0 | % |  |  | 0.0 | %
Reconciliation of Consolidated Stockholders’ Equity Accounts The following table summarizes the Company’s changes in stockholders’ equity accounts for the three and nine months ended September 30, 2025 (in thousands, except share data):
| Convertible Preferred Stock |  |  | Common Stock |  |  | Additional Paid-in |  |  | Accumulated Other Comprehensive |  |  | Accumulated |  |  | Total Stockholders' |
| Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Gain (Loss) |  |  | Deficit |  |  | Equity |
Balance at December 31, 2024 |  | 2,755,086 |  |  | $ | 3 |  |  |  | 113,928,279 |  |  | $ | 114 |  |  | $ | 1,716,335 |  |  | $ | 268 |  |  | $ | (1,397,994 | ) |  | $ | 318,726 |
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 675,631 |  |  |  | 1 |  |  |  | (1 | ) |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7,381 |  |  |  | — |  |  |  | — |  |  |  | 7,381 |
Unrealized loss on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (77 | ) |  |  | — |  |  |  | (77 | )
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (37,621 | ) |  |  | (37,621 | )
Balance at March 31, 2025 |  | 2,755,086 |  |  | $ | 3 |  |  |  | 114,603,910 |  |  | $ | 115 |  |  | $ | 1,723,715 |  |  | $ | 191 |  |  | $ | (1,435,615 | ) |  | $ | 288,409 |
Exercise of stock options, net of issuance costs |  | — |  |  |  | — |  |  |  | 832 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 832 |
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 50,325 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 50,325 |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 7,154 |  |  |  | — |  |  |  | — |  |  |  | 7,154 |
Unrealized loss on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (129 | ) |  |  | — |  |  |  | (129 | )
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (34,070 | ) |  |  | (34,070 | )
Balance at June 30, 2025 |  | 2,755,086 |  |  | $ | 3 |  |  |  | 114,655,067 |  |  | $ | 115 |  |  | $ | 1,730,869 |  |  | $ | 62 |  |  | $ | (1,469,685 | ) |  | $ | 261,364 |
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 681,630 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 681,630 |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,861 |  |  |  | — |  |  |  | — |  |  |  | 4,861 |
Unrealized gain on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 91 |  |  |  | — |  |  |  | 91 |
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (32,250 | ) |  |  | (32,250 | )
Balance at September 30, 2025 |  | 2,755,086 |  |  | $ | 3 |  |  |  | 115,336,697 |  |  | $ | 115 |  |  | $ | 1,735,730 |  |  | $ | 153 |  |  | $ | (1,501,935 | ) |  | $ | 234,066 |
The following table summarizes the Company’s changes in stockholders’ equity accounts for the three and nine months ended September 30, 2024 (in thousands, except share data):
| Convertible Preferred Stock |  |  | Common Stock |  |  | Additional Paid-in |  |  | Accumulated Other Comprehensive |  |  | Accumulated |  |  | Total Stockholders' |
| Shares |  |  | Amount |  |  | Shares |  |  | Amount |  |  | Capital |  |  | Gain (Loss) |  |  | Deficit |  |  | Equity |
Balance at December 31, 2023 |  | 2,761,108 |  |  | $ | 3 |  |  |  | 98,627,076 |  |  | $ | 99 |  |  | $ | 1,580,032 |  |  | $ | 15 |  |  | $ | (1,211,732 | ) |  | $ | 368,417 |
Exercise of stock options, net of issuance costs |  | — |  |  |  | — |  |  |  | 45,438 |  |  |  | — |  |  |  | 299 |  |  |  | — |  |  |  | — |  |  |  | 299 |
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 580,974 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 10,981 |  |  |  | — |  |  |  | — |  |  |  | 10,981 |
Public offering of common stock, net of issuance costs |  | — |  |  |  | — |  |  |  | 14,545,454 |  |  |  | 15 |  |  |  | 74,620 |  |  |  | — |  |  |  | — |  |  |  | 74,635 |
Private placement of pre-funded warrants, net of issuance costs |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 19,996 |  |  |  | — |  |  |  | — |  |  |  | 19,996 |
Unrealized loss on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (209 | ) |  |  | — |  |  |  | (209 | )
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (48,004 | ) |  |  | (48,004 | )
Balance at March 31, 2024 |  | 2,761,108 |  |  | $ | 3 |  |  |  | 113,798,942 |  |  | $ | 114 |  |  | $ | 1,685,928 |  |  | $ | (194 | ) |  | $ | (1,259,736 | ) |  | $ | 426,115 |
Exercise of stock options, net of issuance costs |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4 | ) |  |  | — |  |  |  | — |  |  |  | (4 | )
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 50,615 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9,630 |  |  |  | — |  |  |  | — |  |  |  | 9,630 |
Public offering of common stock, net of issuance costs |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (104 | ) |  |  | — |  |  |  | — |  |  |  | (104 | )
Unrealized loss on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (228 | ) |  |  | — |  |  |  | (228 | )
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (38,427 | ) |  |  | (38,427 | )
Balance at June 30, 2024 |  | 2,761,108 |  |  | $ | 3 |  |  |  | 113,849,557 |  |  | $ | 114 |  |  | $ | 1,695,450 |  |  | $ | (422 | ) |  | $ | (1,298,163 | ) |  | $ | 396,982 |
Issuance of common stock upon vesting of restricted stock units |  | — |  |  |  | — |  |  |  | 35,327 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 11,765 |  |  |  | — |  |  |  | — |  |  |  | 11,765 |
Unrealized gain on investments |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,257 |  |  |  | — |  |  |  | 1,257 |
Net loss |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (47,678 | ) |  |  | (47,678 | )
Balance at September 30, 2024 |  | 2,761,108 |  |  | $ | 3 |  |  |  | 113,884,884 |  |  | $ | 114 |  |  | $ | 1,707,215 |  |  | $ | 835 |  |  | $ | (1,345,841 | ) |  | $ | 362,326 |

X
- Definition Convertible preferred stock and stockholders' equity. + References No definition available. + Details
Name: | fate_ConvertiblePreferredStockAndStockholdersDeficitDisclosureAbstract
Namespace Prefix: | fate_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration